LIVN · NASDAQ · STOCK
LivaNova (LIVN) Stock Analysis
$76.35
52W $48.82 – $85.76
66/100
$4.20B
22.1
0.88
Is LIVN Bullish or Bearish?
Bullish.
Innellis AI committee rates LivaNova (LIVN) Buy with a composite score of 66/100
, based on 5 analysts with 80% agreement.
Last updated October 14, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +9.20 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -10.80 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Growth Analyst sees a compelling case — 5 consecutive earnings beats -- consistent execution. Portfolio Manager remains cautious — 2 existing position pair(s) are highly correlated already. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- ROE of 15.4% shows genuine earnings power backing the valuation — Value
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- News sentiment is positive (+0.20 across 5 articles, 14d) — News
Bear Case
- Lower Highs / Lower Lows structure confirms bearish price action.
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 14, 2026
Overall Committee Score
66/100
Agreement
80%
Analysts
5
Conviction
High
Sector Rank
Top 3%
of 192 Healthcare peers
Value Analyst
bullish
65
/ 100 · High confidence
Classic value case: cheap on multiples with earnings power to back it up
+ ROE of 15.4% shows genuine earnings power backing the valuation
Growth Analyst
bullish
77
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ 5 consecutive earnings beats -- consistent execution
Technical Analyst
neutral
58
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
64
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.20 across 5 articles, 14d)
Portfolio Manager
bearish
35
/ 100 · Low confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− 2 existing position pair(s) are highly correlated already
Investment Thesis Evolution
Committee score weakened from 68.8 to 65.8.
- Bullish support removed: 1 signal(s) disappeared.
- Bearish pressure eased: 1 signal(s) disappeared.
Analyst-level changes:
- Macro Analyst: score 80->65 (-15).
- Portfolio Manager: score 30->35 (+5).
Comparing 2026-10-13 to 2026-10-14 (1 day apart).
Technical Analysis
RSI (14)
45.7
Neutral
MACD Histogram
0.136
Bullish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Lh Ll
Support
$75.94
Resistance
$81.69
Bollinger %B
0.38
Inside Bands
Price vs Moving Averages
EMA 9
$76.29
Above
EMA 21
$76.85
Below
EMA 50
$77.75
Below
EMA 200
$72.04
Above
Fundamental Analysis
Valuation
82
Growth
92
Profitability
41
Financial Health
77
Cash Flow
70
Valuation
P/E Ratio
22.1×
P/B Ratio
3.17×
PEG Ratio
0.08
Dividend Yield
0.00%
52W High
$85.76
52W Low
$48.82
Quality & Growth
ROE
-2020.8%
ROA
-930.5%
Gross Margin
6817.6%
Operating Margin
1347.6%
Revenue Growth YoY
—
Debt / Equity
0.27
AI Fundamental Assessment
P/E ratio of 22.1 (inexpensive relative to a 15-40x range); Price-to-book of 3.2x; PEG ratio of 0.1 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -20.2%; Return on assets of -9.3%; Net margin of 12.8%; Gross margin of 68.2%; Current ratio of 1.45 (tight short-term liquidity); Debt-to-equity of 0.27; Free cash flow per share is positive (2.70); Most recent quarter beat estimates by 12.3%; 5 consecutive earnings beats; EPS growth accelerating (+14.0% -> +28.6% QoQ); Average YoY EPS growth of 20.0%; Analyst estimates rising over recent quarters
Get the Full LIVN Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →